Rhythm Pharmaceuticals, Inc. is listed in the United States. Sector: Healthcare. Industry: Biotechnology.
Rhythm Pharmaceuticals, Inc. (RYTM): research close 116.61 USD on 2026-11-17. 52-week range 75.82 to 117.62 USD. Historical research data, not advice.
| Fact | Figure | As of |
|---|---|---|
| Historical research close | 116.61 USD | 2026-11-17 |
| Previous research close | 107.48 USD | 2026-11-16 |
| Change between the two dated research closes | 8.49% | 2026-11-16 – 2026-11-17 |
| Market capitalisation | 7.37 billion USD | 2026-11-16 |
| 52-week range of the research close | 75.82 – 117.62 USD | 2025-11-18 – 2026-11-17 |
| One-year change in the research close | 15.81% | 2025-11-17 – 2026-11-17 |
| Average daily turnover (20 sessions) | 192.91 million USD | 2026-11-17 |
Source: us_closes_adjusted · US · research close
Historical research prices; adjustments vary by market. This is not a live quote or a forecast.
RYTM is at position 1 of 1 names on the United States Hotlist for the session of 17 November 2026.
Data as of 15:59 ET.
Open the United States Hotlist
Members can compare available company evidence and explicitly save RYTM to a watchlist. A company is saved only after Save is pressed for it.
Free membership opens nine research tools, starting with the Hotlist: the stocks drawing unusual turnover each session.
Nine member offerings. Free. No card.
Join freeResearch, not advice.
Glossary: AVWAP · Date of Control · Beta · Loading · Market cap · Cost of equity · Implied rate